AH receptor-controlled transcriptional regulation and function of rat and human UDP-glucuronosyltransferase isoforms

Advances in Enzyme Regulation

Volumn 38, Issue 1, 1998, Pages 207-222

  Bock, Karl Walter ^a   Gschaidmeier, Harald ^a   Heel, Horst ^a   Lehmköster, Tobias ^a   Münzel, Peter A ^a   Raschko, Frank ^a   Bock Hennig, Barbara ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 4 AMINOHIPPURIC ACID; AROMATIC HYDROCARBON RECEPTOR; GLUCURONIC ACID; GLUCURONOSYLTRANSFERASE; ISOENZYME; MESSENGER RNA; POLYCYCLIC AROMATIC HYDROCARBON;

ANIMAL; ANIMAL CELL; CELL CULTURE; CHEMICAL STRUCTURE; CONFERENCE PAPER; DETOXIFICATION; DRUG METABOLISM; ENZYME SPECIFICITY; ENZYME SUBSTRATE COMPLEX; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; KINETICS; METABOLISM; NONHUMAN; RAT; REPORTER GENE; TRANSCRIPTION REGULATION;

ANIMALS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENES, REPORTER; GLUCURONATES; GLUCURONOSYLTRANSFERASE; HUMANS; ISOENZYMES; KINETICS; MOLECULAR STRUCTURE; POLYCYCLIC HYDROCARBONS, AROMATIC; RATS; RECEPTORS, ARYL HYDROCARBON; RNA, MESSENGER; TETRACHLORODIBENZODIOXIN; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

ANIMALIA; FELIS CATUS;

EID: 0031873379     PISSN: 00652571     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0065-2571(97)00013-7     Document Type: Conference Paper

References (54)

1. G. J. DUTTON, Glucuronidation of Drugs and Other Compounds. CRC Press, Boca Raton, Florida (1980).
2. D. W. NEBERT, Proposed role of drug-metabolizing enzymes: Regulation of steady state levels of the ligands that effect growth, homeostasis, differentiation, and neuroendocrine functions, Mol. Endocrinol. 5, 1203-1214 (1991).
3. D. W. NEBERT, Drug-metabolizing enzymes in ligand-modulated transcription, Biochem. Pharmacol. 47, 25-37 (1994).
4. B. BURCHELL, D. W. NEBERT, D. R. NELSON, K. W. BOCK, T. IYANAGI, P. L. M. JANSEN, D. LANCET, G. J. MULDER, R. J. CHOWDHURY, G. SIEST, T. R. TEPHLY and P. I. MACKENZIE, The UDP-glucuronosyl transferase gene superfamily: Suggested nomenclature based on evolutionary divergence, DNA and Cell Biol. 7, 487-494 (1991).
5. P. I. MACKENZIE, I. S. OWENS, B. BURCHELL, K. W. BOCK, A. BAIROCH, A. BELANGER, S. FOURNEL-GIGLEUX, M. GREEN, D. W. HUM, T. IYANAGI, D. LANCET, P. LOUISOT, J. MAGDALOU, JR, J. K. RITTER, H. SCHACHTER, T. R. TEPHLY, K. F. TIPTON and D. W. NEBERT, The UDP-glucuronosyltransferase gene superfamily: Recommended nomenclature update based on evolutionary divergence, Pharmacogenetics 7, 255-269 (1997).
6. J. K. RITTER, F. CHEN, Y. Y. SHEEN, H. M. TRAN, S. KIMURA, M. T. YEATMAN and I. S. OWENS, A novel complex locus UGT1 encodes human bilirubin, phenol and other UDP-glucuronosyltransferase isoenzymes with identical carboxyl termini, J. Biol. Chem. 267, 3257-3261 (1992).
7. T. IYANAGI, Molecular basis of multiple UDP-glucuronosyltransferase isoenzyme deficiencies in the hyperbilirubinemic rat (Gunn rat), J. Biol. Chem. 266, 24048-24052 (1991).
8. B. BURCHELL, M. W. H. COUGHTRIE and P. L. M. JANSEN, Function and regulation of UDP-glucuronosyltransferase genes in health and liver disease: Report of the Seventh International Workshop on Glucuronidation, September 1993, Pitlochry, Scotland, Hepatology 20, 1622-1630 (1994).
9. J. K. INSCOE and J. AXELROD, Some factors affecting glucuronide formation in vitro, J. Pharmacol. Exp. Ther. 129, 128-131 (1960).
10. K. W. BOCK, W. FRÖHLING, H. REMMER and B. REXER, Effects of phenobarbital and 3-methylcholanthrene on substrate specificity of rat liver microsomal UDP-glucuronyltransferase, Biochim. Biophys. Acta 327, 46-56 (1973).
11. K. W. BOCK, D. JOSTING, W. LILIENBLUM and H. PFEIL, Purification of rat liver microsomal UDP-glucuronyltransferase, Eur. J. Biochem. 98, 19-26 (1979).
12. K. W. BOCK, G. SCHIRMER, M. D. GREEN and T. R. TEPHLY, Properties of a 3-methylcholanthrene-inducible phenol UDP-glucuronosyltransferase from rat liver, Biochem. Pharmacol. 37, 1439-1443 (1988).
13. K. W. BOCK, H.-P. LIPP and B. S. BOCK-HENNIG, Induction of drug-metabolizing enzymes by xenobiotics, Xenobiotica 20, 1101-1111 (1990).
14. J. C. MUCKLOW, H. S. FRASER, C. J. BULPITT, C. KAHN, G. MOULD and C. T. DOLLERY, Environmental factors affecting paracetamol metabolism in London factory and office workers, Br. J. Clin. Pharmacol. 10, 67-74 (1980).
15. E. J. PANTUCK, C. B. PANTUCK, K. E. ANDERSON, L. W. WATTENBERG, A. H. CONNEY and A. KAPPAS, Effect of brussels sprouts and cabbage on drug conjugation, Clin. Pharmacol. Ther. 35, 161-169 (1984).
16. T. WALLE, U. K. WALLE, T. D. COWART, E. C. CONRADI and T. E. GAFFNEY, Selective induction of propranolol metabolism by smoking: Additional effects on renal clearance of metabolites, J. Pharmacol. Exp. Ther. 241, 928-933 (1987).
17. K. W. BOCK, J. WILTFANG, R. BLUME, D. ULLRICH and J. BIRCHER, Paracetamol as a test drug to determine glucuronide formation in man. Effects of inducers and of smoking, Eur. J. Clin. Pharmacol. 31, 677-683 (1987).
18. K. W. BOCK, D. SCHRENK, A. FORSTER, E.-U. GRIESE, K. MÖRIKE, D. BROCKMEIER and M. EICHELBAUM, The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes, Pharmacogenetics 4, 209-218 (1994).
19. A. D. GROVE, F. K. KESSLER, R. P. METZ and J. K. RITTER, Identification of a rat oltipraz-inducible UDP-glucuronosyltransferase (UGT1A7) with activity towards benzo(a)pyrene-7,8-dihydrodiol, J. Biol. Chem. 272, 1621-1627 (1997).
20. P. A. MÜNZEL, G. BOOKJANS, G. MEHNER, T. LEHMKÖSTER and K. W. BOCK, Tissue-specific 2,3,7,8-tetrachlorodibenzo-p-dioxin-inducible expression of human UDP-glucuronosyltransferase UGT1A6, Arch. Biochem. Biophys. 335, 205-210 (1996).
21. P. A. MÜNZEL, M. BRÜCK and K. W. BOCK, Tissue-specific constitutive and inducible expression of rat phenol UDP-glucuronosyltransferase, Biochem. Pharmacol. 47, 1445-1448 (1994).
22. T. EBNER and B. BURCHELL, Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 gene family, Drug Metab. Disp. 21, 50-55 (1993).
23. R. P. REMMEL and B. BURCHELL, Validation and use of cloned, expressed human drug-metabolizing enzymes in heterologous cells for analysis of drug metabolism and drug-drug interactions, Biochem. Pharmacol. 46, 559-566 (1993).
24. K. W. BOCK, A. FORSTER, H. GSCHAIDMEIER, M. BRÜCK, P. MÜNZEL, W. SCHARECK, S. FOURNEL-GIGLEUX and B. BURCHELL, Paracetamol glucuronidation by recombinant rat and human phenol UDP-glucuronosyl transferases, Biochem. Pharmacol. 45, 1809-1814 (1993).
25. I. CARO, X. BOULENC, M. ROUSSET, V. MEUNIER, M. BOURRIE, B. JULIAN, J. JOYEUX, C. ROQUES, Y. BERGER, A. ZWEIBAUM and G. FABRE, Characterisation of a newly isolated Caco-2 clone (TC-7), as a model of transport processes and biotransformation of drugs, Int. J. Pharmaceut. 116, 147-158 (1995).
26. M. GÖTTLICHER, P. CIKRYT and F. J. WIEBEL, Inhibition of growth by 2,3,7,8-tetrachlorodibenzo-p-dioxin in 5L rat hepatoma cells is associated with the presence of Ah receptor, Carcinogenesis 11, 2205-2210 (1990).
27. K. W. BOCK, P. A. MÜNZEL, E. RÖHRDANZ, D. SCHRENK and L. C. ERIKSSON, Persistently increased expression of a 3-methylcholanthrene-inducible phenol UDP-glucuronosyltransferase in rat hepatocyte nodules and hepatocellular carcinomas, Cancer Res. 50, 3569-3573 (1990).
28. J. CHIRGWIN, A. E. PRZYBYLA, R. J. MACDONALD and W. J. RUTTER, Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease, Biochemistry 18, 5294-5299 (1979).
29. D. HARDING, S. FOURNEL-GIGLEUX, M. R. JACKSON and B. BURCHELL, Cloning and substrate specificity of a human phenol UDP-glucuronosyl transferase expressed in COS-7 cells, Proc. Natl. Acad. Sci. U.S.A. 85, 8381-8385 (1988).
30. R. WOOSTER, L. SUTHERLAND, T. EBNER, D. CLARKE, O. DA CRUZ E SILVA and B. BURCHELL, Cloning and stable expression of a new member of the human liver phenol/bilirubin: UDP-glucuronosyltransferase cDNA family, Biochem. J. 278, 465-469 (1991).
31. P. CHOMCZYNSKI and N. SACCHI, Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction, Anal. Biochem. 162, 156-159 (1987).
32. M. J. SLEIGH, A nonchromatographic assay for expression of the chloramphenicol acetyltransferase gene in eucaryotic cells, Anal. Biochem. 156, 251-256 (1986).
33. W. LILIENBLUM, A. K. WALLI and K. W. BOCK, Differential induction of rat liver microsomal UDP-glucuronyltransferase activities by various inducing agents, Biochem. Pharmacol. 31, 907-913 (1982).
34. K. W. BOCK, H. GSCHAIDMEIER, A. SEIDEL, S. BAIRD and B. BURCHELL, Mono and diglucuronide formation from chrysene and benzo(a)pyrene phenols by 3-methylcholanthrene-inducible phenol UDP-glucuronosyltransferase (UGT1A1), Mol. Pharmacol. 42, 613-618 (1992).
35. O. H. LOWRY, N. J. ROSEBROUGH, A. L. FARR and R. J. RANDALL, Protein measurement with the Folin phenol reagent, J. Biol. Chem. 193, 265-275 (1951).
36. T. IYANAGI, M. HANIU, K. SOGAWA, Y. FUJII-KURIYAMA, S. WATANABE, J. E. SHIVELY and K. F. ANAN, Cloning and characterization of cDNA encoding 3-methylcholanthrene inducible rat mRNA for UDP-glucuronosyl transferase, J. Biol. Chem. 261, 15607-15614 (1986).
37. D. ULLRICH, P. A. MÜNZEL, S. BECK-GSCHAIDMEIER, M. SCHRÖDER and K. W. BOCK, Drug-metabolizing enzymes in pharyngeal mucosa and in oropharyngeal cancer tissue, Biochem. Pharmacol. 54, 1159-1162 (1997).
38. J. G. LAMB, P. STRAUB and R. H. TUKEY, Cloning and characterization of cDNAs encoding mouse Ugtl.6 and rabbit UGT1.6: Differential induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin, Biochemistry 39, 10513-10520 (1994).
39. P. FERNANDEZ-SALGUERO, P. PINEAU, D. M. HILBERT, T. MCPHAIL, S. S. T. LEE, S. KIMURA, D. W. NEBERT, S. RUDIKOFF, J. M. WARD and F. J. GONZALEZ, Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor, Science 268, 722-726 (1995).
40. Y. EMI, S-I. IKUSHIRO and T. IYANAGI, Xenobiotic responsive element-mediated transcriptional activation in the UDP-glucuronosyltransferase family 1 gene complex, J. Biol. Chem. 271, 3952-3958 (1996).
41. E. FARBER, Cellular biochemistry of the stepwise development of cancer with chemicals, Cancer Res. 44, 5463-5474 (1984).
42. H. GSCHAIDMEIER, A. SEIDEL, F. OESCH, B. BURCHELL and K. W. BOCK, Formation of mono- and diglucuronides and of other glycosides of benzo(a)-pyrene-3,6-quinol by V79 cell-expressed human phenol UDP-glucuronosyltransferases of the UGT1 gene complex, Biochem. Pharmacol. 49, 1601-1606 (1995).
43. W. LILIENBLUM, K. L. PLATT, G. SCHIRMER, F. OESCH and K. W. BOCK, Regioselectivity of rat liver microsomal UDP-glucuronosyltransferase activities toward phenols of benzo(a)pyrene and dibenzo(a,h)anthracene, Mol. Pharmacol. 32, 173-177 (1987).
44. D. R. BEVAN and V. M. SADLER, Quinol diglucuronides are predominant conjugated metabolites found in bile of rats following intratracheal instillation of benzo(a)-pyrene, Carcinogenesis 13, 403-407 (1992).
45. W. LILIENBLUM, B. S. BOCK-HENNIG and K. W. BOCK, Protection against toxic redox cycles between benzo(a)pyrene-3,6-quinone and its quinol by 3-methylcholanthrene-inducible formation of the quinol mono- and diglucuronide, Mol. Pharmacol. 27, 451-458 (1985).
46. S-I. IKUSHIRO, Y. EMI and T. IYANAGI, Protein-protein interactions between UDP-glucuronosyltransferase isozymes in rat hepatic microsomes, Biochemistry 36, 7154-7161 (1997).
47. H. GSCHAIDMEIER and K. W. BOCK, Radiation inactivation analysis of microsomal UDP-glucuronosyltransferases catalysing mono- and diglucuronide formation of 3,6-dihydroxybenzo(a)pyrene and 3,6-dihydroxychrysene, Biochem. Pharmacol. 48, 1545-1549 (1994).
48. P. I. MACKENZIE, L. RODBOURN and T. IYANAGI, Glucuronidation of carcinogen metabolites by complementary DNA-expressed uridine 5′-diphosphate glucuronosyltransferases, Cancer Res. 53, 1529-1533 (1993).
49. C.-F. JIN, J. O. MINERS, B. BURCHELL and P. I. MACKENZIE, The glucuronidation of hydroxylated metabolites of benzo(a)pyrene and 2-acetylaminofluorene by cDNA-expressed human UDP-glucuronosyl transferases, Carcinogenesis 14, 2637-2639 (1993).
50. Z. HU and P. G. WELLS, In vitro and in vivo biotransformation and covalent binding of benzo(a)pyrene in Gunn and RHA rats with a genetic deficiency in bilirubin uridine diphosphate-glucuronosyltransferase, J. Pharmacol. Exp. Ther. 263, 334-342 (1992).
51. D. W. NEBERT, The Ah locus. A gene with possible importance in cancer predictability, Arch. Toxicol. (Suppl.) 3, 195-207 (1980).
52. I. GOTO, S. YONEDA, M. YAMAMOTO and K. KAWAJIRI, Prognostic significance of germ line polymorphisms of the CYP1A1 and glutathione S-transferase genes in patients with non-small cell lung cancer, Cancer Res. 56, 3725-3730 (1996).
53. T. PRESTERA and P. TALALAY, Electrophile and antioxidant regulation of enzymes that detoxify carcinogens, Proc. Natl. Acad. Sci. U.S.A. 92, 8965-8969 (1995).
54. P. TALALAY, J. W. FAHEY, W. D. HOLTZCLAW, T. PRESTERA and Y. ZHANG, Chemoprotection against cancer by phase 2 enzyme induction, Toxicol. Letters 82/83, 173-179 (1995).